|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.45 HKD | -0.51% |
|
+22.25% | -19.56% |
| 06-25 | 3Sbio Inc. Declares a Final Dividend for the Year Ended 31 December 2025 | CI |
| 05-28 | Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom | RE |
| Market Cap | 42.09B 48.59B 6.2B 5.43B 5B 4.64B 8.81B 591B 8.93B 59.82B 23.28B 290B 23.27B 22.75B 1,006B | P/E 2026 * |
15.5x | P/E 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 29.53B 34.08B 4.35B 3.81B 3.51B 3.25B 6.18B 415B 6.26B 41.96B 16.33B 203B 16.32B 15.96B 706B | EV / Sales 2026 * |
2.83x | EV / Sales 2027 * | 2.52x |
| Free-Float |
74.93% | Yield 2026 * |
1.46% | Yield 2027 * | 1.62% |
| 1 day | -0.51% | ||
| 1 week | +22.25% | ||
| Current month | +15.16% | ||
| 1 month | +24.04% | ||
| 3 months | -23.36% | ||
| 6 months | -25.13% | ||
| Current year | -19.56% |
| 1 week | 16.72 |  | 20.9 |
| 1 month | 14.81 | | 20.9 |
| Current year | 14.81 | | 29.3 |
| 1 year | 14.81 | | 36.8 |
| 3 years | 4.91 | | 36.8 |
| 5 years | 4.72 | | 36.8 |
| 10 years | 4.72 | | 36.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 63 | 2005-12-31 |
Xiang He
DFI | Director of Finance/CFO | - | 2023-07-02 |
Dong Mei Su
PRN | Corporate Officer/Principal | 56 | 2014-11-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Jing Lou
CHM | Chairman | 63 | 2012-04-02 |
Dong Mei Su
BRD | Director/Board Member | 56 | 2012-06-10 |
Tian Ruo Pu
BRD | Director/Board Member | 57 | 2015-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-07 | Other | Chief Executive Officer | 516,000 | 0.0203% | ||
| 25-07-28 | Other | Chief Executive Officer | 440,000 | 0.0184% | ||
| 25-04-14 | Other | Director | 26,000 | 0.0011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | +22.25% | -23.58% | +160.37% | 6.23B | |
| -1.03% | +2.35% | +20.17% | -8.26% | 66.56B | |
| -1.97% | -3.45% | +49.74% | +221.13% | 56.51B | |
| -1.13% | +40.50% | +40.50% | +40.50% | 42.98B | |
| +1.99% | +8.15% | -48.83% | -54.69% | 40.46B | |
| -1.49% | -1.87% | +63.35% | -25.41% | 31.91B | |
| +2.02% | +16.80% | +172.27% | -31.18% | 31.65B | |
| -1.25% | +0.31% | +70.97% | +82.96% | 23.35B | |
| +3.08% | +20.43% | +4.99% | +186.85% | 19.46B | |
| +0.21% | +3.76% | +67.83% | +133.69% | 17.18B | |
| Average | -0.02% | +10.46% | +41.74% | +70.60% | 33.63B | |
| Weighted average by Cap. | -0.31% | +7.97% | +42.12% | +55.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.45B 12.06B 1.54B 1.35B 1.24B 1.15B 2.19B 147B 2.22B 14.85B 5.78B 71.99B 5.77B 5.65B 250B | 11.01B 12.71B 1.62B 1.42B 1.31B 1.21B 2.31B 155B 2.34B 15.65B 6.09B 75.91B 6.09B 5.95B 263B |
| Net income | 2.83B 3.26B 416M 364M 336M 312M 592M 39.7B 600M 4.02B 1.56B 19.49B 1.56B 1.53B 67.56B | 2.9B 3.34B 426M 373M 344M 319M 606M 40.65B 614M 4.11B 1.6B 19.95B 1.6B 1.57B 69.18B |
| Net Debt | -12.56B -14.5B -1.85B -1.62B -1.49B -1.38B -2.63B -176B -2.66B -17.86B -6.95B -86.58B -6.94B -6.79B -300B | -14.36B -16.58B -2.11B -1.85B -1.71B -1.58B -3.01B -202B -3.05B -20.41B -7.94B -98.99B -7.94B -7.77B -343B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-06 | HK$19.45 | -0.51% | 74,038,304 |
| 26-07-03 | HK$19.55 | +7.77% | 59,243,139 |
| 26-07-02 | HK$18.14 | +7.40% | 54,478,083 |
| 26-06-30 | HK$16.89 | -2.26% | 29,240,677 |
| 26-06-29 | HK$17.28 | +8.61% | 53,608,189 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1530 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
